Quarterly report · Q2
6856.TEDINET S100P17D
Period2022-01-01 → 2022-06-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥115.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥224.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥101.3bn | 2021-01-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥16.3bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥13.1bn | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥32.0bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.0bn | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.0bn | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.3bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.7bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥8.7bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥398.4bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥371.6bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥349.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥173.8bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥167.1bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥224.6bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥204.5bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥191.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥140.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥135.0bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥139.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥133.9bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥122.0bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥114.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.3bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥15.8bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.7bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥6.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.1bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥266.31 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥130.72 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥505.05 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.24 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥114.81 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥264.93 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥502.46 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥206.2 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 56.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.8% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.7% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥1.8bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥162m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥638m |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥765m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥16.8bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥24.9bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥24.9bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2021-01-01 → 2021-06-30 | −¥1.2bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥12.9bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥12.9bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥326m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥464m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥40.0bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥40.0bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥12.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 560
| Item | Context | Value | Unit |
|---|---|---|---|
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -69000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 7484000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 20455000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 791000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 771000000 | JPY |
| Non controlling interests | Prior1YearInstant | 12000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 6000000 | JPY |
| Net assets | Prior1YearInstant | 204493000000 | JPY |
| Net assets | CurrentQuarterInstant | 224647000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 371585000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 398397000000 | JPY |
| Net sales | Prior1YTDDuration | 101317000000 | JPY |
| Net sales | CurrentYTDDuration | 114965000000 | JPY |
| Cost of sales | Prior1YTDDuration | 58516000000 | JPY |
| Cost of sales | CurrentYTDDuration | 66051000000 | JPY |
| Gross profit | Prior1YTDDuration | 42800000000 | JPY |
| Gross profit | CurrentYTDDuration | 48913000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 29731000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 32653000000 | JPY |
| Operating income | Prior1YTDDuration | 13069000000 | JPY |
| Operating income | CurrentYTDDuration | 16260000000 | JPY |
| Interest income noi | Prior1YTDDuration | 101000000 | JPY |
| Interest income noi | CurrentYTDDuration | 156000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 109000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 138000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | － | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 252000000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 52000000 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 100000000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 108000000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 234000000 | JPY |
| Non operating income | Prior1YTDDuration | 372000000 | JPY |
| Non operating income | CurrentYTDDuration | 882000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 232000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 287000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | 103000000 | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | － | JPY |
| Miscellaneous loss noe | Prior1YTDDuration | 58000000 | JPY |
| Miscellaneous loss noe | CurrentYTDDuration | 69000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 394000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 357000000 | JPY |
| Ordinary income | Prior1YTDDuration | 13047000000 | JPY |
| Ordinary income | CurrentYTDDuration | 16784000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 7000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 9000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 6000000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 20000000 | JPY |
| Gain on reversal of subscription rights to shares ei | Prior1YTDDuration | － | JPY |
| Gain on reversal of subscription rights to shares ei | CurrentYTDDuration | 1000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 14000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |